Scholar Rock Holding Corporation (NASDAQ:SRRK – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen ratings firms that are currently covering the firm, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, one has given a hold recommendation, ten have given a buy recommendation and four have assigned a strong buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $67.67.
Several research analysts recently commented on SRRK shares. Wedbush reiterated an “outperform” rating and issued a $64.00 target price on shares of Scholar Rock in a report on Tuesday, September 15th. JPMorgan Chase & Co. lifted their price target on shares of Scholar Rock from $63.00 to $70.00 and gave the stock an “overweight” rating in a research note on Monday, September 21st. Citigroup upped their target price on shares of Scholar Rock from $60.00 to $74.00 and gave the company a “buy” rating in a research note on Monday, September 14th. Jefferies Financial Group upped their price objective on Scholar Rock from $57.00 to $65.00 and gave the company a “buy” rating in a research note on Monday, September 14th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Scholar Rock in a research report on Thursday, October 15th.
Check Out Our Latest Stock Report on Scholar Rock
Insiders Place Their Bets
Hedge Funds Weigh In On Scholar Rock
Several institutional investors and hedge funds have recently made changes to their positions in SRRK. BlackRock Inc. acquired a new stake in Scholar Rock during the 2nd quarter valued at $522,175,000. Redmile Group LLC raised its position in shares of Scholar Rock by 73.7% in the first quarter. Redmile Group LLC now owns 9,066,621 shares of the company’s stock valued at $445,715,000 after purchasing an additional 3,845,775 shares during the period. Jupiter Topco LLC acquired a new stake in shares of Scholar Rock during the 2nd quarter worth about $123,279,000. Bank of America Corp DE acquired a new stake in shares of Scholar Rock during the 2nd quarter worth about $53,474,000. Finally, Eagle Health Investments LP bought a new stake in shares of Scholar Rock during the 2nd quarter worth about $30,540,000. Institutional investors and hedge funds own 91.08% of the company’s stock.
Scholar Rock Stock Down 2.3%
Shares of Scholar Rock stock opened at $42.91 on Tuesday. The stock has a 50-day simple moving average of $48.20 and a 200-day simple moving average of $48.18. Scholar Rock has a 52-week low of $27.07 and a 52-week high of $61.76. The firm has a market cap of $5.23 billion, a price-to-earnings ratio of -12.44 and a beta of 0.61. The company has a debt-to-equity ratio of 0.77, a current ratio of 7.02 and a quick ratio of 7.02.
Scholar Rock (NASDAQ:SRRK – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported ($0.84) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.84). During the same quarter last year, the business posted ($0.98) earnings per share. On average, equities research analysts expect that Scholar Rock will post -3.29 earnings per share for the current fiscal year.
About Scholar Rock
Scholar Rock, Inc is a biotechnology company focused on developing medicines that selectively target growth factors in the transforming growth factor beta (TGF-β) superfamily. The company’s research is intended to address serious diseases in which these signaling pathways play an important role, including neuromuscular and metabolic conditions.
Scholar Rock’s lead investigational product is apitegromab, a monoclonal antibody designed to inhibit the activation of myostatin, a protein that limits muscle growth.
See Also
- Five stocks we like better than Scholar Rock
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for Scholar Rock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scholar Rock and related companies with MarketBeat.com's FREE daily email newsletter.
